Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Abroad (travel likely)RecruitingPHASE2

Conditions

Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea, Seoul, South Korea
Contact: Study coordinator (Kim Wonseog, phD) · wonseog.kim@samsung.com · 82-10-9933-5823
Contact: Study coordinator (shin hyunjung) · hjds.shin@samsung.com · 82-2-3410-6763

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Santa Monica, United States · Stanford, United States

Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma

Follicular Lymphoma

Abroad (travel likely)RecruitingPHASE2

Tianjin, China · Tianjin, China

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Chronic Lymphocytic Leukemia · CLL · Mantle Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tampa, United States · Fort Wayne, United States

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States